NCI is pleased to announce that Gregory Reaman, MD, FASCO, is the new Scientific Director of the Childhood Cancer Data Initiative (CCDI). Dr. Reaman joined the CCDI Leadership Team several months ago and has been part of CCDI since the beginning of the initiative. He comes to NCI with a career dedicated to caring for children with cancer and improving childhood cancer research.
Dr. Reaman has practiced medicine as a pediatric hematologist-oncologist and has held leadership positions in organizations like the U.S. Food and Drug Administration, Children’s Oncology Group, Children’s National Hospital in Washington, D.C., and George Washington University School of Medicine. He is especially interested in the biology and treatment of childhood acute leukemia and has helped transform new drug development for childhood cancers.
As Scientific Director, Dr. Reaman will develop, direct, and coordinate CCDI’s programs and initiatives. He will provide scientific oversight and recommendations to drive CCDI’s vision and progress, with the needs of the childhood cancer community in mind. With his leadership and commitment to advancing research, we will continue to ensure that CCDI works toward improving outcomes for all children, adolescents, and young adults with cancer.